Digirad Corp. : DRAD-US: Dividend Analysis : November 20th, 2017 (record date) : By the numbers : November 20, 2017

Our analysis is based on comparing Digirad Corp. with the following peers – RadNet, Inc., American Shared Hospital Services, Fonar Corporation, Community Health Systems, Inc., Tenet Healthcare Corporation, Concord Medical Services Holding Ltd. ADR and iCAD, Inc. (RDNT-US, AMS-US, FONR-US, CYH-US, THC-US, CCM-US and ICAD-US).

Dividend Yield
Dividend Quality Score

Dividend Quality Overview

  • Over the last twelve months (prior to September 30, 2017), DRAD-US paid a low quality dividend, which represents a yield of 8.57% at the current price.
  • Dividend quality trend has not been consistent over the last five years. Dividends were paid during 4 of these years — of these 2 were high quality and 2 were low quality.
  • The ending cash balance is less than the last full year dividend payment and cannot be relied on to cushion any significant reduction of cash flows in the future.
Dividend Quality Score Vs Dividend Yield

Quadrant label definitions. Hover to know more

High Score;High Yield, High Score;Low Yield, Low Score;Low Yield, Low Score;High Yield

Dividend Coverage

Over the last twelve months (prior to September 30, 2017), DRAD-US paid a low quality dividend.

The source of the company’s cash to support the dividend paid over the last twelve months is operating cash flow (coverage of 1.99x), investing cash flow (coverage of -0.55x), issuance cash flow (coverage of -0.75x) and twelve-month prior cash (coverage of 0.96x), for a total dividend coverage of 1.38x.

DRAD-US’s issuance cash flow includes outflows from net debt repayment (coverage of -1.45x).

Dividend Coverage by Cash Flow (TTM)

These coverage ratio factors imply that the firm had to dip into the beginning cash balance to pay the dividend, which suggests a low dividend quality.

Dividend History

Item 2012-12-31 2013-12-31 2014-12-31 2015-12-31 2016-12-31 Latest
Dividend Yield (%) 0 1.35 4.57 3.41 3.93 8.57
Dividend Payout (%) 0 1000 153.85 18.18 28.17 -36.21

A complete list of metrics and analysis is available on the company page.

Company Profile

Digirad Corp. engages in the design and development of diagnostic imaging solutions. It operates through the Imaging Solutions and Diagnostic Imaging segments. The Imaging Solutions segment offers in-office nuclear cardiology imaging and ultrasound services to physician practices, hospitals, and imaging centers. The Diagnostic Imaging segment sells medical diagnostic imaging systems, such as gamma cameras for nuclear cardiology and general nuclear medicine applications. The company founded in 1997 and is headquartered in Suwanee, GA.


The information presented in this report has been obtained from sources deemed to be reliable, but AnalytixInsight does not make any representation about the accuracy, completeness, or timeliness of this information. This report was produced by AnalytixInsight for informational purposes only and nothing contained herein should be construed as an offer to buy or sell or as a solicitation of an offer to buy or sell any security or derivative instrument. This report is current only as of the date that it was published and the opinions, estimates, ratings and other information may change without notice or publication. Past performance is no guarantee of future results. Prior to making an investment or other financial decision, please consult with your financial, legal and tax advisors. AnalytixInsight shall not be liable for any party’s use of this report. AnalytixInsight is not a broker-dealer and does not buy, sell, maintain a position, or make a market in any security referred to herein. One of the principal tenets for us at AnalytixInsight is that the best person to handle your finances is you. By your use of our services or by reading any our reports, you’re agreeing that you bear responsibility for your own investment research and investment decisions. You also agree that AnalytixInsight, its directors, its employees, and its agents will not be liable for any investment decision made or action taken by you and others based on news, information, opinion, or any other material generated by us and/or published through our services. For a complete copy of our disclaimer, please visit our website www.analytixinsight.com.